Scientists from VIB and KU Leuven, together with colleagues from the University of California and the Swiss Institute for Experimental Cancer Research have demonstrated that, anti-angiogenic therapy can improve immune boosting treatments. The successful combination of these two therapies results in the growth of specialized vessels that deliver cancer-fighting immune cells to the tumor, potentially...